Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Operating income | -$4.13M | -$3.31M | -$12.4M | -$10.7M | -$18.0M | -$20.7M | -$23.8M | -$31.1M | -$21.2M | -$15.5M |
| Net income | -$4.13M | -$3.31M | -$12.4M | -$10.7M | -$17.9M | -$20.7M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| EPS (diluted) | -$0.38 | -$0.29 | -$0.90 | -$0.66 | -$0.51 | -$0.42 | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$1.25M | -$2.17M | -$6.85M | -$6.92M | -$13.9M | -$14.3M | -$17.6M | -$24.7M | -$17.9M | -$15.3M |
| Capital expenditures | $4.98K | $5.89K | $22.4K | $33.4K | $17.6K | $31.7K | $0.00 | — | — | — |
| Free cash flow | -$1.25M | -$2.18M | -$6.87M | -$6.95M | -$14.0M | -$14.3M | -$17.6M | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.60M | $161K | — | — | — | — | $21.0M | $6.74M | $1.60M | $7.83M |
| Total assets | $1.91M | $1.26M | $9.27M | $3.53M | $31.4M | $42.9M | $25.1M | $10.7M | $4.12M | $10.2M |
| Total liabilities | — | — | — | — | — | $1.59M | $2.38M | — | $2.50M | $2.20M |
| Shareholders' equity | $1.62M | $429K | $8.88M | $3.02M | $30.9M | $41.3M | $22.3M | $7.42M | $1.62M | $7.96M |
| Retained earnings | -$14.1M | -$17.5M | -$29.8M | -$40.5M | -$58.4M | -$79.1M | -$103M | -$134M | -$155M | -$171M |
| Shares (wtd avg diluted) | 11.4M | 11.7M | 15.2M | 19.3M | 43.1M | 47.1M | 1.20M | 1.37M | 80.1B | 933K |
Every figure is extracted from Genprex, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.